
AC Biode – Chemical Technology for a more Sustainable Future
AC Biode developed a diverse portfolio of products based on chemical technology designed to provide more sustainable alternatives to conventional practices.
AC Biode developed a diverse portfolio of products based on chemical technology designed to provide more sustainable alternatives to conventional practices.
The awards are designed to recognise pioneering ideas and showcase the vital role vinyl plays.
Cellasto, the world leader in Noise, Vibration and Harshness (NVH) components, is investing roughly €60 million to establish a second plant in Shanghai, China.
A new, mid-size Contract Development Manufacturing Organisation (CDMO), Meribel Pharma Solutions, has launched today with an extensive integrated network across Europe.
Scientifica Venture Capital, in collaboration with the Institut des Relations Economiques France-Italie (IREFI), has unveiled the winners of the Super Sapiens Europe initiative.
To meet growing demand from the pharmaceutical industry, Asahi Kasei has established Asahi Kasei Life Science to operate its bioprocess businesses under a new organizational structure.
Novo Nordisk continues its sizeable manufacturing investments to meet increasing drug demands.
Strategic Value Partners (SVP) and Blantyre Capital Limited (Blantyre) recently announced the acquisition of OQ Chemicals (Oxea), a leading global producer and merchant of oxo chemicals.
Ethris and Lonza have teamed up to develop room-temperature stable, spray-dried mRNA vaccines for respiratory diseases. This collaboration aims to create mucosal delivery formulations, offering a promising new approach to combat respiratory illnesses.
Solvay has officially inaugurated its rare earths production line for permanent magnets at the La Rochelle facility, marking a significant milestone in the Group’s commitment to meeting Europe’s strategic goals.
Oncodesign Services has appointed Aidan Synnott as chief executive officer to help strengthen its position as a trusted partner in drug discovery.
Veranova welcomes Scott Zugel as Global VP of Analytical Research Development Operations.
NBE Therapeutics (NBE), a wholly owned subsidiary of Boehringer Ingelheim, officially opened its new ADC R&D facility in Basel.
HAS Healthcare Advanced Synthesis (HAS) recently announced the planned acquisition of Cerbios-Pharma (Cerbios), a globally recognized manufacturer of chemical and biological APIs, including antibody-drug conjugates (ADCs).
The completion of the deal marks the third major investment by Ineos Energy in the USA in the past three years. It increases Ineos' capital spending on energy assets in the USA to above $3 billion.
New facility will focus on crosslinkers and binders, with the potential to test tens of thousands of formulations per year. Digitalization and automation enable data-driven research and development, while networked robotics allow more efficient data generation for segment-specific application testing.
Ineos Enterprises has completed the sale of its composites business to KPS Capital Partners, LP (“KPS”) for ~€1.7 billion.
The Seqens Group, a global manufacturer of health, personal care, and specialty ingredients, recently announced a strategic partnership with Novonesis, a sustainable biological solutions provider.
Vynova Alkoxides GmbH is beginning the construction of a new alcoholates plant at Chemiepark Lülsdorf GmbH in Lülsdorf, Germany.
US healthcare giant Johnson & Johnson (J&J) has unveiled plans to invest over $55 billion in the US over the next four years. This significant investment marks a 25% increase compared to the previous four years, the company said.
The Global Impact Coalition (GIC), a collaborative platform led by CEOs and focused on achieving a net-zero chemicals future, has announced the addition of Moeve as its newest member.
MSD (Merck & Co.) and Hengrui Pharma recently announced that they have entered into an exclusive license agreement for HRS-5346, an investigational oral small molecule Lipoprotein(a) inhibitor.
Europe's chemical industry is in crisis, warns the European Chemical Industry Council (CEFIC) President Ilham Kadri, urging EU leaders to act on a 10-point rescue plan to prevent further shutdowns and loss of investments.
JFE Steel, Mitsubishi Gas Chemical, and Mitsubishi Chemical collaborate to develop a carbon recycling supply chain at Mizushima Complex.
OMV has announced the expansion of its innovative ReOil technology at the Schwechat refinery near Vienna.
The Indian, woman-led startup Coco Custo is pioneering more sustainable cleaning solutions with its biodegradable laundry detergent and other eco-friendly cleaning powders. Formulated primarily from plant-based ingredients and minerals, including organic oils and coconut, Coco Custo’s products are non-toxic, hypoallergenic, and free from harmful chemicals.
Britain’s AstraZeneca wants to invest $2.5 billion in Beijing, China to establish its sixth global strategic R&D center.
Sudden shifts in demand, supply shortages and global collapse have put immense pressure on pharmaceutical logistics. To address these challenges, PHARMAP 2025 brings together industry experts to discover AI-driven supply chain optimisation, strategic logistics partnerships and digital solutions that enhance efficiency and resilience in the pharmaceutical supply chain.
Arkema has announced the launch of its Carat Project at its Carling site in France. This initiative aims to enhance the capabilities and sustainability of the facility, which specializes in producing acrylic monomers and superabsorbent polymers.
Diversity, equity, and inclusion (DE&I) initiatives have become increasingly important for attracting diverse perspectives, improving problem solving and advancing innovation in companies.
Inseit, based in Bern, develops biocatalysts for industrial setups using enzyme immobilization and biocomputation. Addressing biotech and sustainability challenges, Inseit was selected for Venture Leaders Biotech and won two Nucleate accelerator prizes.
Porelio's FOMS adsorbents target PFAS, metals, and genotoxins, outperforming commercial solutions with unmatched selectivity, innovation, and sustainability.
The pharmaceutical industry requires reliable and innovative partners who can flexibly adapt to its changing demands.
This interview covers key results of the study ‘Success Factor Supply Chain Management and Logistics in the Chemical Industry 2024’ by Solventure, Aimms and Miebach.
The EU Green Deal has hurt Europe's industry. The Clean Industrial Deal aims to improve this, but a change of mindset at the Commission is needed.